These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry. Ning S; Barty R; Liu Y; Heddle NM; Rochwerg B; Arnold DM Chest; 2016 Sep; 150(3):516-23. PubMed ID: 27102183 [TBL] [Abstract][Full Text] [Related]
11. Platelet transfusion therapy. Aisner J Med Clin North Am; 1977 Sep; 61(5):1133-45. PubMed ID: 330975 [TBL] [Abstract][Full Text] [Related]
12. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience. Karlström C; Linjama T; Edgren G; Lauronen J; Wikman A; Höglund P Transfusion; 2019 Mar; 59(3):945-952. PubMed ID: 30575964 [TBL] [Abstract][Full Text] [Related]
13. Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Murphy MF; Brozovic B; Murphy W; Ouwehand W; Waters AH Transfus Med; 1992 Dec; 2(4):311-8. PubMed ID: 1339584 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic use of platelets in critically ill patients with thrombocytopaenia: A retrospective two-centre observational study. O'Bryan LJ; Bedford J; Redfern OC; Hatch RA; Young JD; Watkinson PJ J Crit Care; 2020 Jun; 57():157-167. PubMed ID: 32163751 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to human platelet antigens form a significant proportion of platelet antibodies detected in Indian patients with refractoriness to platelet transfusions. Abraham AS; Chacko MP; Fouzia NA; Srivastava A; Daniel D Transfus Med; 2018 Oct; 28(5):392-397. PubMed ID: 29460307 [TBL] [Abstract][Full Text] [Related]
16. Pathogen-reduced platelets for the prevention of bleeding. Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569 [TBL] [Abstract][Full Text] [Related]
17. Platelet transfusions: the problem of refractoriness. Murphy MF; Waters AH Blood Rev; 1990 Mar; 4(1):16-24. PubMed ID: 2182145 [TBL] [Abstract][Full Text] [Related]
18. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets. Levy L; Woodfield DG N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558 [TBL] [Abstract][Full Text] [Related]
19. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES. Gubanova MN; Ayupova RF; Zhiburt EB Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588 [TBL] [Abstract][Full Text] [Related]
20. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites]. Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]